The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prokinetic Drug Sales Market Report 2024
Synopsis
A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
Market Analysis and Insights: Global Prokinetic Drug Market
The global Prokinetic Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Prokinetic Drug Scope and Market Size
The global Prokinetic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prokinetic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Metoclopramide
Domperidone
Cisapride
Others
Segment by Application
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
The Prokinetic Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Prokinetic Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm
A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
Market Analysis and Insights: Global Prokinetic Drug Market
The global Prokinetic Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Prokinetic Drug Scope and Market Size
The global Prokinetic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prokinetic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Metoclopramide
Domperidone
Cisapride
Others
Segment by Application
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
The Prokinetic Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Prokinetic Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm
Index1 Prokinetic Drug Market Overview
1.1 Prokinetic Drug Product Scope
1.2 Prokinetic Drug Segment by Type
1.2.1 Global Prokinetic Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Metoclopramide
1.2.3 Domperidone
1.2.4 Cisapride
1.2.5 Others
1.3 Prokinetic Drug Segment by Application
1.3.1 Global Prokinetic Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Gastroparesis
1.3.3 Constipation
1.3.4 Reflux Esophagitis
1.3.5 Functional Dyspepsia
1.4 Prokinetic Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Prokinetic Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Prokinetic Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Prokinetic Drug Price Trends (2016-2027)
2 Prokinetic Drug Estimates and Forecasts by Region
2.1 Global Prokinetic Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Prokinetic Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Prokinetic Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Prokinetic Drug Revenue Market Share by Region (2016-2021)
2.3 Global Prokinetic Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Prokinetic Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Prokinetic Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Prokinetic Drug Estimates and Projections (2016-2027)
2.4.2 Europe Prokinetic Drug Estimates and Projections (2016-2027)
2.4.3 China Prokinetic Drug Estimates and Projections (2016-2027)
2.4.4 Japan Prokinetic Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Prokinetic Drug Estimates and Projections (2016-2027)
2.4.6 India Prokinetic Drug Estimates and Projections (2016-2027)
3 Global Prokinetic Drug Competition Landscape by Players
3.1 Global Top Prokinetic Drug Players by Sales (2016-2021)
3.2 Global Top Prokinetic Drug Players by Revenue (2016-2021)
3.3 Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prokinetic Drug as of 2020)
3.4 Global Prokinetic Drug Average Price by Company (2016-2021)
3.5 Manufacturers Prokinetic Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Prokinetic Drug Market Size by Type
4.1 Global Prokinetic Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Prokinetic Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Prokinetic Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Prokinetic Drug Price by Type (2016-2021)
4.2 Global Prokinetic Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Prokinetic Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Prokinetic Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Prokinetic Drug Price Forecast by Type (2022-2027)
5 Global Prokinetic Drug Market Size by Application
5.1 Global Prokinetic Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Prokinetic Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Prokinetic Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Prokinetic Drug Price by Application (2016-2021)
5.2 Global Prokinetic Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Prokinetic Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Prokinetic Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Prokinetic Drug Price Forecast by Application (2022-2027)
6 North America Prokinetic Drug Market Facts & Figures
6.1 North America Prokinetic Drug Sales by Company
6.1.1 North America Prokinetic Drug Sales by Company (2016-2021)
6.1.2 North America Prokinetic Drug Revenue by Company (2016-2021)
6.2 North America Prokinetic Drug Sales Breakdown by Type
6.2.1 North America Prokinetic Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Prokinetic Drug Sales Breakdown by Type (2022-2027)
6.3 North America Prokinetic Drug Sales Breakdown by Application
6.3.1 North America Prokinetic Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Prokinetic Drug Sales Breakdown by Application (2022-2027)
7 Europe Prokinetic Drug Market Facts & Figures
7.1 Europe Prokinetic Drug Sales by Company
7.1.1 Europe Prokinetic Drug Sales by Company (2016-2021)
7.1.2 Europe Prokinetic Drug Revenue by Company (2016-2021)
7.2 Europe Prokinetic Drug Sales Breakdown by Type
7.2.1 Europe Prokinetic Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Prokinetic Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Prokinetic Drug Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)
8 China Prokinetic Drug Market Facts & Figures
8.1 China Prokinetic Drug Sales by Company
8.1.1 China Prokinetic Drug Sales by Company (2016-2021)
8.1.2 China Prokinetic Drug Revenue by Company (2016-2021)
8.2 China Prokinetic Drug Sales Breakdown by Type
8.2.1 China Prokinetic Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Prokinetic Drug Sales Breakdown by Type (2022-2027)
8.3 China Prokinetic Drug Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Prokinetic Drug Market Facts & Figures
9.1 Japan Prokinetic Drug Sales by Company
9.1.1 Japan Prokinetic Drug Sales by Company (2016-2021)
9.1.2 Japan Prokinetic Drug Revenue by Company (2016-2021)
9.2 Japan Prokinetic Drug Sales Breakdown by Type
9.2.1 Japan Prokinetic Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Prokinetic Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Prokinetic Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Prokinetic Drug Market Facts & Figures
10.1 Southeast Asia Prokinetic Drug Sales by Company
10.1.1 Southeast Asia Prokinetic Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Prokinetic Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Prokinetic Drug Sales Breakdown by Type
10.2.1 Southeast Asia Prokinetic Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Prokinetic Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Prokinetic Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Prokinetic Drug Market Facts & Figures
11.1 India Prokinetic Drug Sales by Company
11.1.1 India Prokinetic Drug Sales by Company (2016-2021)
11.1.2 India Prokinetic Drug Revenue by Company (2016-2021)
11.2 India Prokinetic Drug Sales Breakdown by Type
11.2.1 India Prokinetic Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Prokinetic Drug Sales Breakdown by Type (2022-2027)
11.3 India Prokinetic Drug Sales Breakdown by Application
11.3.1 India Prokinetic Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Prokinetic Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Prokinetic Drug Business
12.1 Sumitomo
12.1.1 Sumitomo Corporation Information
12.1.2 Sumitomo Business Overview
12.1.3 Sumitomo Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sumitomo Prokinetic Drug Products Offered
12.1.5 Sumitomo Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Prokinetic Drug Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Prokinetic Drug Products Offered
12.3.5 Sanofi Recent Development
12.4 Kyowa Kirin Pharmaceuticals
12.4.1 Kyowa Kirin Pharmaceuticals Corporation Information
12.4.2 Kyowa Kirin Pharmaceuticals Business Overview
12.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Products Offered
12.4.5 Kyowa Kirin Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Prokinetic Drug Products Offered
12.5.5 Pfizer Recent Development
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Business Overview
12.6.3 Teva Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Prokinetic Drug Products Offered
12.6.5 Teva Recent Development
12.7 Cadila Pharmaceuticals
12.7.1 Cadila Pharmaceuticals Corporation Information
12.7.2 Cadila Pharmaceuticals Business Overview
12.7.3 Cadila Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cadila Pharmaceuticals Prokinetic Drug Products Offered
12.7.5 Cadila Pharmaceuticals Recent Development
12.8 Hanmi Pharm
12.8.1 Hanmi Pharm Corporation Information
12.8.2 Hanmi Pharm Business Overview
12.8.3 Hanmi Pharm Prokinetic Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hanmi Pharm Prokinetic Drug Products Offered
12.8.5 Hanmi Pharm Recent Development
13 Prokinetic Drug Manufacturing Cost Analysis
13.1 Prokinetic Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Prokinetic Drug
13.4 Prokinetic Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Prokinetic Drug Distributors List
14.3 Prokinetic Drug Customers
15 Market Dynamics
15.1 Prokinetic Drug Market Trends
15.2 Prokinetic Drug Drivers
15.3 Prokinetic Drug Market Challenges
15.4 Prokinetic Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of TablesList of Tables
Table 1. Global Prokinetic Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Prokinetic Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Prokinetic Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Prokinetic Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Prokinetic Drug Sales Market Share by Region (2016-2021)
Table 6. Global Prokinetic Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Prokinetic Drug Revenue Share by Region (2016-2021)
Table 8. Global Prokinetic Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Prokinetic Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Prokinetic Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Prokinetic Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Prokinetic Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Prokinetic Drug Sales Share by Company (2016-2021)
Table 14. Global Prokinetic Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Prokinetic Drug Revenue Share by Company (2016-2021)
Table 16. Global Prokinetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prokinetic Drug as of 2020)
Table 17. Global Prokinetic Drug Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Prokinetic Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Prokinetic Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Prokinetic Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Prokinetic Drug Sales Share by Type (2016-2021)
Table 23. Global Prokinetic Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Prokinetic Drug Price (US$/Unit) by Type (2016-2021)
Table 25. Global Prokinetic Drug Sales Share by Type (2022-2027)
Table 26. Global Prokinetic Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Prokinetic Drug Revenue Share by Type (2022-2027)
Table 28. Global Prokinetic Drug Price (US$/Unit) by Type (2022-2027)
Table 29. Global Prokinetic Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Prokinetic Drug Sales Share by Application (2016-2021)
Table 31. Global Prokinetic Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Prokinetic Drug Price (US$/Unit) by Application (2016-2021)
Table 33. Global Prokinetic Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Prokinetic Drug Sales Share by Application (2022-2027)
Table 35. Global Prokinetic Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Prokinetic Drug Revenue Share by Application (2022-2027)
Table 37. Global Prokinetic Drug Price (US$/Unit) by Application (2022-2027)
Table 38. North America Prokinetic Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Prokinetic Drug Sales Market Share by Company (2016-2021)
Table 40. North America Prokinetic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Prokinetic Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Prokinetic Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Prokinetic Drug Sales Market Share by Type (2016-2021)
Table 44. North America Prokinetic Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Prokinetic Drug Sales Market Share by Type (2022-2027)
Table 46. North America Prokinetic Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Prokinetic Drug Sales Market Share by Application (2016-2021)
Table 48. North America Prokinetic Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Prokinetic Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Prokinetic Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Prokinetic Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Prokinetic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Prokinetic Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Prokinetic Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Prokinetic Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Prokinetic Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Prokinetic Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Prokinetic Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Prokinetic Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Prokinetic Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Prokinetic Drug Sales Market Share by Application (2022-2027)
Table 62. China Prokinetic Drug Sales (K Units) by Company (2016-2021)
Table 63. China Prokinetic Drug Sales Market Share by Company (2016-2021)
Table 64. China Prokinetic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Prokinetic Drug Revenue Market Share by Company (2016-2021)
Table 66. China Prokinetic Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Prokinetic Drug Sales Market Share by Type (2016-2021)
Table 68. China Prokinetic Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Prokinetic Drug Sales Market Share by Type (2022-2027)
Table 70. China Prokinetic Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Prokinetic Drug Sales Market Share by Application (2016-2021)
Table 72. China Prokinetic Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Prokinetic Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Prokinetic Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Prokinetic Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Prokinetic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Prokinetic Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Prokinetic Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Prokinetic Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Prokinetic Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Prokinetic Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Prokinetic Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Prokinetic Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Prokinetic Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Prokinetic Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Prokinetic Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Prokinetic Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Prokinetic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Prokinetic Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Prokinetic Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Prokinetic Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Prokinetic Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Prokinetic Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Prokinetic Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Prokinetic Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Prokinetic Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Prokinetic Drug Sales Market Share by Application (2022-2027)
Table 98. India Prokinetic Drug Sales (K Units) by Company (2016-2021)
Table 99. India Prokinetic Drug Sales Market Share by Company (2016-2021)
Table 100. India Prokinetic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Prokinetic Drug Revenue Market Share by Company (2016-2021)
Table 102. India Prokinetic Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Prokinetic Drug Sales Market Share by Type (2016-2021)
Table 104. India Prokinetic Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Prokinetic Drug Sales Market Share by Type (2022-2027)
Table 106. India Prokinetic Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Prokinetic Drug Sales Market Share by Application (2016-2021)
Table 108. India Prokinetic Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Prokinetic Drug Sales Market Share by Application (2022-2027)
Table 110. Sumitomo Corporation Information
Table 111. Sumitomo Description and Business Overview
Table 112. Sumitomo Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Sumitomo Prokinetic Drug Product
Table 114. Sumitomo Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Prokinetic Drug Product
Table 119. Johnson & Johnson Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Sanofi Prokinetic Drug Product
Table 124. Sanofi Recent Development
Table 125. Kyowa Kirin Pharmaceuticals Corporation Information
Table 126. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 127. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product
Table 129. Kyowa Kirin Pharmaceuticals Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Pfizer Prokinetic Drug Product
Table 134. Pfizer Recent Development
Table 135. Teva Corporation Information
Table 136. Teva Description and Business Overview
Table 137. Teva Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Teva Prokinetic Drug Product
Table 139. Teva Recent Development
Table 140. Cadila Pharmaceuticals Corporation Information
Table 141. Cadila Pharmaceuticals Description and Business Overview
Table 142. Cadila Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Cadila Pharmaceuticals Prokinetic Drug Product
Table 144. Cadila Pharmaceuticals Recent Development
Table 145. Hanmi Pharm Corporation Information
Table 146. Hanmi Pharm Prokinetic Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Hanmi Pharm Description and Business Overview
Table 148. Hanmi Pharm Prokinetic Drug Product
Table 149. Hanmi Pharm Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Prokinetic Drug Distributors List
Table 153. Prokinetic Drug Customers List
Table 154. Prokinetic Drug Market Trends
Table 155. Prokinetic Drug Market Drivers
Table 156. Prokinetic Drug Market Challenges
Table 157. Prokinetic Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Prokinetic Drug Product Picture
Figure 2. Global Prokinetic Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Prokinetic Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Gastroparesis Examples
Figure 7. Constipation Examples
Figure 8. Reflux Esophagitis Examples
Figure 9. Functional Dyspepsia Examples
Figure 10. Global Prokinetic Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Prokinetic Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Prokinetic Drug Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Prokinetic Drug Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 14. Global Prokinetic Drug Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Prokinetic Drug Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Prokinetic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Prokinetic Drug Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Prokinetic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Prokinetic Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Prokinetic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Prokinetic Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Prokinetic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Prokinetic Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Prokinetic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Prokinetic Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Prokinetic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Prokinetic Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Prokinetic Drug Players Market Share by Revenue in Prokinetic Drug: 2016 & 2020
Figure 29. Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Prokinetic Drug Revenue Share by Type (2016-2021)
Figure 31. Global Prokinetic Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Prokinetic Drug Revenue Share by Application (2016-2021)
Figure 33. Global Prokinetic Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Prokinetic Drug Sales Market Share by Type in 2020
Figure 35. North America Prokinetic Drug Sales Market Share by Application in 2020
Figure 36. Europe Prokinetic Drug Sales Market Share by Type in 2020
Figure 37. Europe Prokinetic Drug Sales Market Share by Application in 2020
Figure 38. China Prokinetic Drug Sales Market Share by Type in 2020
Figure 39. China Prokinetic Drug Sales Market Share by Application in 2020
Figure 40. Japan Prokinetic Drug Sales Market Share by Type in 2020
Figure 41. Japan Prokinetic Drug Sales Market Share by Application in 2020
Figure 42. Southeast Asia Prokinetic Drug Sales Market Share by Type in 2020
Figure 43. Southeast Asia Prokinetic Drug Sales Market Share by Application in 2020
Figure 44. India Prokinetic Drug Sales Market Share by Type in 2020
Figure 45. India Prokinetic Drug Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Prokinetic Drug
Figure 48. Manufacturing Process Analysis of Prokinetic Drug
Figure 49. Prokinetic Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
